Aytu Biopharma Inc (AYTU)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2400 -0.0100 (-0.80%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.2400 unch (unch) 16:00 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,262 | 1,474 | -15,844 | -11,227 | -8,340 |
| Depreciation Amortization | 2,821 | 1,454 | 8,869 | 6,791 | 3,936 |
| Accounts receivable | -1,794 | 478 | 5,320 | -988 | -1,566 |
| Accounts payable and accrued liabilities | 1,329 | 3,143 | -2,879 | N/A | -3,062 |
| Other Working Capital | 2,384 | -854 | -4,660 | -4,618 | -5,035 |
| Other Operating Activity | -5,287 | -6,885 | 7,806 | 9,442 | 13,721 |
| Operating Cash Flow | $1,715 | $-1,190 | $-1,388 | $-600 | $-346 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 526 | 381 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -329 | -295 | -250 |
| Investing Cash Flow | $526 | $381 | $-329 | $-295 | $-250 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,617 | 1,875 | 832 | 18 | -537 |
| Debt Issued | N/A | N/A | 13,000 | N/A | N/A |
| Debt Repayment | -3,466 | -964 | -18,288 | -2,274 | -2,249 |
| Common Stock Issued | N/A | N/A | 3,467 | 86 | 86 |
| Other Financing Activity | 0 | 0 | -273 | -160 | -160 |
| Financing Cash Flow | $-1,849 | $911 | $-1,262 | $-2,330 | $-2,860 |
| Beginning Cash Position | 20,006 | 20,006 | 22,985 | 22,985 | 22,985 |
| End Cash Position | 20,398 | 20,108 | 20,006 | 19,760 | 19,529 |
| Net Cash Flow | $392 | $102 | $-2,979 | $-3,225 | $-3,456 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,715 | -1,190 | -1,388 | -600 | -346 |
| Capital Expenditure | -142 | -136 | N/A | N/A | N/A |
| Free Cash Flow | 1,573 | -1,326 | -1,388 | -600 | -346 |